1. Share gains are becoming commercially visible
- Global share more than doubled to 10%, while flagship-phone adoption demonstrates product qualification.
CXMT is converting domestic demand and product adoption into share gains, with HBM offering a larger strategic upside.
CXMT’s growth ambitions are capital-intensive, while technology, execution, and industry-supply constraints could delay returns.
Rosenblatt says CXMT’s planned YE26 4F² DDR5 RDIMM does not establish near-term competitiveness: at ~17nm vs. leaders near ~12nm, CXMT’s 4F² cell would still be ~34% larger than a leading 6F² cell, while yields, wafer volumes and high-volume economics remai...
WDC/STX -5-6% and Memory -5% leading the way lower. Some pointing to the CXMT news from yesterday and Musk’s tweet below:
Other reasons for the sell-off we heard today: NVDA’s reported Reflection AI acquisition talks raising more competition concerns. Nadella’s call for an AI “emergency brake” although investors seem increasingly desensitized to safety headlines. Elsewhere: Me...
CXMT’s board approved $5.2 billion for R&D and DRAM testing, including $24.1 billion for process development and $10.8 billion for testing and module assembly, with equipment representing 93% of the R&D budget.
The projects require shareholder approval and have 30- and 37-month construction schedules.
CXMT’s contracted investment commitments rose 206% to $52.44 billion in H1, while expanding HBM production at rival suppliers continues to constrain conventional DRAM supply.
Morgan Stanley prefers beneficiaries where stronger inference meets limited supply or rising complexity, including CXMT.
CXMT is rapidly closing the gap in advanced DRAM, with global share reaching 10% in Q2, up from 4% a year ago, and Xiaomi adopting its latest mobile memory in a flagship phone.
Goldman estimates CXMT could supply ~40% of China’s HBM demand by 2028, making its progress increasingly relevant for the broader memory cycle.
MS prefers beneficiaries where stronger inference meets limited supply or rising complexity, including NVDA, MediaTek/GUC, GLW/LITE/COHR and CXMT, while favoring STM/NXP/Renesas for non-AI diversification.
Research through 2026-10-19 · 2026-07-27 to 2026-10-19 · 8 source reports.
| Range | Prices through |
|---|---|
| 1W | |
| 1M | |
| 3M | |
| 6M | |
| 1Y | |
| 2Y | |
| 3Y |
Research through 2026-11-03. Artifact validity does not establish factual accuracy or research freshness.